Skip main navigation

Military Health System

Clear Your Browser Cache

This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.

Skip subpage navigation

DOD P&T Committee: 2012 Meetings

Meeting Date  Drug Classes Under Review/Information for Manufacturers 
February 2012
  • ADHD/Narolepsy
  • Anti-platelet Therapy
  • Diabetes: Non-Insulin
New Drugs
  • Lastacaft
  • Nucynta ER
May 2012 
  • Sedative/Hypnotic
  • Tobacco Cessation Drugs

New Drugs

  • Gralise
  • Horizant
August 2012
  • Androgens-Anabolic Steroids
  • Anticoagulants
New Drugs
  • Bydureon
  • Duesis
  • Janumet XR
  • Jentadueto
  • Orencia
  • Sprix
  • Zioptan
November 2012
  • Hepatitis C Agents
  • Overactive Bladder Agents
  • Gastrointestinal-2 Agents
  • Diabetes: Non-Insulin
New Drugs
  • Oxtecta
Last Updated: April 25, 2024
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery